Literature DB >> 23889628

[Effectiveness of cognitive behavioral therapy on weight loss after two years of bariatric surgery in morbidly obese patients].

V Abilés1, J Abilés, S Rodríguez-Ruiz, V Luna, F Martín, N Gándara, M C Fernández-Santaella.   

Abstract

OBJECTIVE: To evaluate the effectiveness of Cognitive Behavioral Therapy (CBT) in the success of postoperative weight loss after 2 years of CB.
METHODS: A prospective observational study was conducted in consecutive patients with morbid obesity aged between 18 and 59 yrs and enrolled in the bariatric surgery program of the Obesity Surgery Unit of our hospital from June 2007 through June 2010, with two years postoperative follow-up. Participants were divided into two groups according to their participation in Cognitive Behavioral Therapy or not. Over a 3-month period, CBT was applied in 12 2-h sessions. The main dependent variables studied were body weight and height, from which we calculated BMI and percentage of excess weight lost (weight lost x 100)/(initial weight-ideal weight), classifying patients as successful (E ) those with EPP > 50%, and unsuccessful (NE) those with EPP <50%. Participants were also, assessed for general (stress, anxiety, depression and self-esteem) and specific (binge eating and food craving) psychopathology.
RESULTS: Of the 35 patients with bariatric surgery, 30 responded postoperative evaluations, 16 underwent CBT before CB and 14 underwent surgery without receiving psycho-nutritional therapy, (76% female) with a mean age of 41 ± 9.5 years. The mean baseline BMI was 42 ± 10 and 45% of patients were classified as super obese (BMI: 56 ± 6). Mean excess weight loss (EPP) was 77%. According to the EPP were classified as "successful" (S) (59%) and "unsuccessful" (U) (41%). Of the patients assigned to S, 94% received CBT (15 individuals of 17 total), compared with only 12% who did not receive (2 individuals of the 17 total) with statistically significant differences (p < 0.05). Also, the S patients appeared to be significantly less anxious and stressed and have higher self-esteem (P < 0.05). Regarding specific psychopathology, the food craving guided by hunger, loss of control over food intake and guilt was lower in patients who achieved > 50% of EPP (p < 0.04, p < 0.001, p < 0.001, respectively). It was also noted that these patients were plans to eat less and ate less for positive reinforcement (p < 0.03 and p < 0.000, respectively) than the patient group NE.
CONCLUSIONS: Patients who achieved successful results in the evolution of weight loss at two years of CB are mostly (94%) who received CBT, presenting lower psychological comorbidity than NE. CBT could positively influence postoperative outcomes.
Copyright © AULA MEDICA EDICIONES 2013. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23889628     DOI: 10.3305/nh.2013.28.4.6536

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  4 in total

1.  A pilot randomized controlled trial of telephone-based cognitive behavioural therapy for preoperative bariatric surgery patients.

Authors:  Stephanie E Cassin; Sanjeev Sockalingam; Chau Du; Susan Wnuk; Raed Hawa; Sagar V Parikh
Journal:  Behav Res Ther       Date:  2016-03-10

2.  Examination of the Effectiveness of a Brief, Adapted Dialectical Behavior Therapy-Skills Training Group for Bariatric Surgical Candidates.

Authors:  Chelsea A Delparte; Hilary A Power; Bethany L Gelinas; Amanda M Oliver; Regan D Hart; Kristi D Wright
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

3.  Effectiveness of a cognitive behavioral therapy for dysfunctional eating among patients admitted for bariatric surgery: a randomized controlled trial.

Authors:  Hege Gade; Jøran Hjelmesæth; Jan H Rosenvinge; Oddgeir Friborg
Journal:  J Obes       Date:  2014-07-21

Review 4.  How Relevant is Food Craving to Obesity and Its Treatment?

Authors:  Marc N Potenza; Carlos M Grilo
Journal:  Front Psychiatry       Date:  2014-11-19       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.